2M8W

Restrained CS-Rosetta Solution NMR Structure of Staphylococcus aureus protein SAV1430. Northeast Structural Genomics Target ZR18. Structure determination

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	NH HSQC	1.15 mM [U-100% 15N; U-100% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
2	HNCO	1.15 mM [U-100% 15N; U-100% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
3	HNCACB	1.15 mM [U-100% 15N; U-100% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
4	HNCOCACB	1.15 mM [U-100% 15N; U-100% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
7	HCC(CO)NH-TOCSY	1.15 mM [U-100% 15N; U-100% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
8	H(CCCO)NH-TOCSY	1.15 mM [U-100% 15N; U-100% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
9	HACACONH	1.15 mM [U-100% 15N; U-100% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
10	HACANH	1.15 mM [U-100% 15N; U-100% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
11	CH HSQC	1.15 mM [U-100% 15N; U-100% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
12	HCCH-COSY	1.15 mM [U-100% 15N; U-100% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
13	13C EDITED NOESY	1.15 mM [U-100% 15N; U-100% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
14	HBCBCGCDHD RD	1.15 mM [U-100% 15N; U-100% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
15	AROMATICTOCSY RD	1.15 mM [U-100% 15N; U-100% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
16	hetNOE	1.3 mM [U-100% 15N; U-5% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
17	HNHA	1.3 mM [U-100% 15N; U-5% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
18	15N EDITED NOESY	1.15 mM [U-100% 15N; U-100% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298
19	CH HSQC high res.	1.3 mM [U-100% 15N; U-5% 13C] ZR18, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 % NaN3, 5 % D2O	95% H2O/5% D2O	0.1	6.5		298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	UNITY Inova	500
2	Varian	UNITY Inova	600

NMR Refinement
Method	Details	Software
	Structures were calculated by Restrained CS-Rosetta method using NOE-based distance, dihedral angle, and hydrogen bond restraints from the original AutoStructure structure calculations	HYPER

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	10000
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Additional NMR Experimental Information
Details	THE FIRST REPRESENTATIVE STRUCTURE IN THE ENSEMBLE IS THE MEDOID STRUCTURE.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	data analysis	HYPER	3.2	Tejero, Monleon, Celda, Powers and Montelione
2	data analysis	TALOS	2.1	Cornilescu, Delaglio and Bax
3	data collection	VNMR6.1C		Varian
4	raw spectral data processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
5	spectral visualization	Sparky		Goddard
6	automated backbone assignments	AutoAssign		Zimmerman, Moseley, Kulikowski and Montelione
7	integrated spectral analysus software	SPINS		Baran, Montelione
8	integrated spectral analysus software	SPINS		Baran, Montelione
9	refinement	Rosetta

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.